Diabetic Retinopathy, the leading cause of blindness in working-age adults.

The most troubling aspect of DR is that early stages typically result in no noticeable symptoms, yet a lack of symptoms does not indicate lack of damage. Early identification is vital because by the time vision is noticeably impaired, the prognosis for recovery is much more grim. Periodic screenings are essential to catch the issue early, as DR is highly treatable in its initial stages, allowing patients to preserve their sight and long-term independence.

AI technology like EyeArt supports care pathways by providing autonomous, non-invasive screenings that identify DR without requiring human interpretation. This scalable model enables universal access at the point of care, bridging the gap for millions who do not see an eye specialist. By delivering accurate results in under 30 seconds, AI ensures that high-risk patients are fast-tracked to specialists, transforming a standard visit into a life-saving event.